Alveo

Advancing Molecular Testing and Diagnostics | Alveo Technologies

Alameda, United States · Founded 2015 · $38.0M raised

Founded
2015
Business Model
B2B2C
Total Funding
$38.0M
Last Round
$38.0M Series AJan 2018
Rounds
1

About

Alveo Technologies is a molecular diagnostics company headquartered in Alameda, California, founded in 2015 by Sumita Pennathur and Lawrence Blatt. The company has built an open point-of-need pathogen-detection platform used across human health, animal health, food and beverage, and biosecurity applications, holding 24 global patents and multiple co-development partnerships. Alveo's technology has reached more than nine countries through its sales and distribution network, and the company is led by CEO Shaun Holt, a former Berkeley Lights and Illumina finance executive.

Summary

Alveo is a Biotech company based in Alameda, United States, founded in 2015. It has raised $38.0M in total across 1 round, most recently a $38.0M Series A round in Jan 2018.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2018
$38.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alveo on Indexed.vc
<a href="https://indexed.vc/companies/alveo"><img src="https://indexed.vc/api/badge/company/alveo" alt="Alveo on Indexed.vc" width="260" height="76" /></a>